HPV jab using same tech as AstraZeneca Covid vaccine could combat cervical ...

View
comments

The ground-breaking technology behind the Oxford-AstraZeneca Covid vaccine could be used to combat cervical cancer, potentially wiping out early signs of the disease before it has time to progress.

A trial is under way at several NHS hospitals giving more than 50 women who test positive for pre-cancerous tissue on their cervix a specially designed HPV jab.

After a year, researchers will examine whether the pre-cancerous tissue is still on the cervix, along with any traces of HPV (human papillomavirus), an infection which is almost always present when women develop this cancer.

The trial, called Apollo, involves a vaccine called VTP-200, which targets HPV but is different from the HPV jab given to teenagers as it uses an inactivated chimpanzee adenovirus – the same

read more from dailymail.....